APA (7th ed.) Citation

Hou, M., Xing, H., Li, C., Wang, X., Deng, D., Li, J., . . . Chen, J. (2020). Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: A systematic review and meta-analysis. Journal of headache and pain, 21(1), 66-12. https://doi.org/10.1186/s10194-020-01138-x

Chicago Style (17th ed.) Citation

Hou, Min, Haiyan Xing, Chen Li, Xianfeng Wang, Dongmei Deng, Juan Li, Pan Zhang, and Jianhong Chen. "Short-term Efficacy and Safety of Lasmiditan, a Novel 5-HT1F Receptor Agonist, for the Acute Treatment of Migraine: A Systematic Review and Meta-analysis." Journal of Headache and Pain 21, no. 1 (2020): 66-12. https://doi.org/10.1186/s10194-020-01138-x.

MLA (9th ed.) Citation

Hou, Min, et al. "Short-term Efficacy and Safety of Lasmiditan, a Novel 5-HT1F Receptor Agonist, for the Acute Treatment of Migraine: A Systematic Review and Meta-analysis." Journal of Headache and Pain, vol. 21, no. 1, 2020, pp. 66-12, https://doi.org/10.1186/s10194-020-01138-x.